Sign in to view content

Primary Analysis Results of the Phase 3 Archway Trial of the Port Delivery System With Ranibizumab (PDS) for Patients With Neovascular AMD

Peter A. Campochiaro, MD

Video
Published 2020

Related

Optimization of the Port Delivery System With Ranibizumab (PDS) Implant Insertion Procedure in the LADDER Phase 2 Trial
Mark R. Wieland, MD
Annual Meeting Talks
2019
Clinical Experience With the SCS Microinjector for Suprachoroidal Injections by Ophthalmologists
Milan Shah, MD
Annual Meeting Talks
2019
Retinal Physician Practice Patterns in the Setting of Anticoagulation
Allen Chiang, MD, FASRS
On Demand Cases, Courses, and Papers
2017

Category: AMD-Neovascular

See more